Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study

Abstract

Background Longer-term consequences after SARS-CoV-2 infection are becoming an important burden to societies and healthcare systems. Data on post-COVID-19 syndrome in the general population are required for the timely planning of healthcare services and resources. The objective of this study was to assess the prevalence of impaired health status and physical and mental health symptoms among individuals at least six months after SARS-CoV-2 infection, and to characterize their healthcare utilization. Methods This population-based prospective cohort study (Zurich SARS-CoV-2 Cohort) enrolled 431 adults from the general population with polymerase chain reaction-confirmed SARS-CoV-2 infection reported to health authorities between 27 February 2020 and 05 August 2020 in the Canton of Zurich, Switzerland. We evaluated the proportion of individuals reporting not to have fully recovered since SARS-CoV-2 infection, and the proportion reporting fatigue (Fatigue Assessment Scale), dyspnea (mMRC dyspnea scale) or depression (DASS-21) at six to eight months after diagnosis. Furthermore, the proportion of individuals with at least one healthcare contact after their acute illness was evaluated. Multivariable logistic regression models were used to assess factors associated with these main outcomes. Results Symptoms were present in 385 (89%) participants at diagnosis and 81 (19%) were initially hospitalized. At six to eight months, 111 (26%) reported not having fully recovered. 233 (55%) participants reported symptoms of fatigue, 96 (25%) had at least grade 1 dyspnea, and 111 (26%) had DASS-21 scores indicating symptoms of depression. 170 (40%) participants reported at least one general practitioner visit related to COVID-19 after acute illness, and 10% (8/81) of initially hospitalized individuals were rehospitalized. Individuals that have not fully recovered or suffer from fatigue, dyspnea or depression were more likely to have further healthcare contacts. However, a third of individuals (37/111) that have not fully recovered did not seek further care. Conclusions In this population-based study, a relevant proportion of participants suffered from longer-term consequences after SARS-CoV-2 infection. With millions infected across the world, our findings emphasize the need for the timely planning of resources and patient-centered services for post-COVID-19 care.

To Vaccinate or Not to Vaccinate—This Is the Question among Swiss University Students

“…In our study, we find the expected direction of effect; however, it is overall a small effect. Possibly, with increasing knowledge on the shortand long-term health risks, such as long COVID [33,34], and the personal inconveniences resulting from a suspected or true infection, such as isolation or quarantine, the perception of risk has changed.…”

Access to Mental Health Care during the First Wave of the COVID-19 Pandemic in Italy: Results from the COMET Multicentric Study

“…Of note, depression and anxiety showed a sharp increase among the general population during the first weeks after the pandemic outbreak [ 3 ]. Furthermore, depression was hypothesized to be one of the post-COVID-19 features predicting a higher need for psychological support [ 109 ].…”

Development and validation of the Symptom Burden Questionnaire™ for Long Covid: A Rasch analysis

“…As each item of a Rasch-derived scale functions independently from others on that scale, the SBQ™-LC can be adapted for administration as a computer adaptive test (CAT) [39,54]. A CAT is a test, administered via a computer, which adapts to the respondent's ability in real-time by selecting different questions from an item bank to provide a more accurate measure of the respondent's ability without the need to administer a large number of items [55]. CATs can reduce respondent burden, improve accuracy, and provide individualized assessment, instrument characteristics which are attractive when assessing a health condition with heterogeneous, relapsing and remitting symptoms such as Long COVID.…”